Published: 25 February, 2021 | Volume 5 - Issue 1 | Pages: 001-012
Figure 1:
Comparison of dual doses and a single dose of 188Re-liposome on suppression of orthotopic HNSCC tumor model. (A) The experimental scheme of 188Re-liposome treatment and tumor evaluation. (B) Cerenkov luminescent imaging (CLI) of orthotopic tumor treated with 188Re-liposome. (C) Comparison of sizes of the resected tumors from tumor-bearing mice with or without 188Re-liposome treatment.
Read Full Article HTML DOI: 10.29328/journal.hor.1001024 Cite this Article Read Full Article PDF
HSPI: We're glad you're here. Please click "create a new Query" if you are a new visitor to our website and need further information from us.
If you are already a member of our network and need to keep track of any developments regarding a question you have already submitted, click "take me to my Query."